Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alimena

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Cancer Genetics and Cytogenetics|April 1, 1985
Cytogenetic pattern in leukemic cells of patients with constitutional chromosome anomaliesG Alimena, R Billström, R Casalone, et al.
Bone Marrow Transplantation|February 17, 2009
Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect?M Breccia, L Cannella, C Stefanizzi, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
The karyotype of blastic crisisG Alimena, M R De Cuia, D Diverio, et al.
Human Genetics|January 1, 1981
Acute lymphocytic and myelomonocytic leukemia associated with low platelet counts and a 21q- marker chromosomeG Alimena, B Dallapiccola, M R De Cuia, et al.
Haematologica|November 1, 1987
Leukemias and constitutional chromosome pathologyG Alimena, M R De Cuia, D Diverio, et al.
Haematologica|April 1, 1982
5q--chromosome in a case of acute non-lymphocytic leukemia (ANLL): the marker of a polyphasic disease?G Alimena, R Gastaldi, M R De Cuia, et al.
Haematologica|January 1, 1972
[Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia]G Papa, S Amadori, B Monarca, et al.
Recenti Progressi in Medicina|March 1, 1981
[The karyotype in the blastic crisis of chronic myeloid leukemia]G Alimena, R Gastaldi, M R De Cuia, et al.
Recenti Progressi in Medicina|March 1, 1981
[Cytogenetic aspects of secondary leukemias]G Alimena, M R De Cuia, R Gastaldi, et al.
Leukemia Research|March 7, 2008
Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinibM Breccia, M Muscaritoli, L Cannella, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Cancer Genetics and Cytogenetics|April 1, 1985
Cytogenetic pattern in leukemic cells of patients with constitutional chromosome anomaliesG Alimena, R Billström, R Casalone, et al.
Bone Marrow Transplantation|February 17, 2009
Efficacy of dasatinib in a chronic myeloid leukemia patient with disease molecular relapse and chronic GVHD after haploidentical BMT: an immunomodulatory effect?M Breccia, L Cannella, C Stefanizzi, et al.
Cancer Genetics and Cytogenetics|May 1, 1987
The karyotype of blastic crisisG Alimena, M R De Cuia, D Diverio, et al.
Human Genetics|January 1, 1981
Acute lymphocytic and myelomonocytic leukemia associated with low platelet counts and a 21q- marker chromosomeG Alimena, B Dallapiccola, M R De Cuia, et al.
Haematologica|November 1, 1987
Leukemias and constitutional chromosome pathologyG Alimena, M R De Cuia, D Diverio, et al.
Haematologica|April 1, 1982
5q--chromosome in a case of acute non-lymphocytic leukemia (ANLL): the marker of a polyphasic disease?G Alimena, R Gastaldi, M R De Cuia, et al.
Haematologica|January 1, 1972
[Preliminary studies on the effectiveness of the association cytosine-arabinoside, thioguanine, hydroxyureas in the treatment of blastic crisis in chronic myeloid leukemia]G Papa, S Amadori, B Monarca, et al.
Recenti Progressi in Medicina|March 1, 1981
[The karyotype in the blastic crisis of chronic myeloid leukemia]G Alimena, R Gastaldi, M R De Cuia, et al.
Recenti Progressi in Medicina|March 1, 1981
[Cytogenetic aspects of secondary leukemias]G Alimena, M R De Cuia, R Gastaldi, et al.
Leukemia Research|March 7, 2008
Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinibM Breccia, M Muscaritoli, L Cannella, et al.
Pageof 14